![]() |
|
|
Vol. 292, Issue 1, 265-270, January 2000
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo (T.H., H.S., X.-Y.C, Y.S.); and Faculty of Pharmaceutical Sciences, Kanazawa University, Takaramachi, Kanazawa (I.T., A.T.), Japan
| |
Abstract |
|---|
|
|
|---|
Several organic anions are actively extruded from intestinal epithelial
cells into the lumen and vascular sides. To examine the role of
the multidrug resistance-associated protein (MRP) family in the
intestinal efflux of organic anions, the function and expression of
these proteins were investigated with Caco-2, a human adenocarcinoma
cell line that retains many of the characteristics of normal
enterocytes.
[3H]2,4-Dinitrophenyl-S-glutathione
(DNP-SG) and [3H]17
-estradiol
17-
-D-glucuronide (E217
G), typical
substrates for MRP1 and cMOAT (canalicular multispecific organic anion
transporter)/MRP2, were taken up into brush-border membrane vesicles
(BBMVs) from Caco-2 in an ATP-dependent manner, with
Km values of 16.9 ± 7.2 and 9.4 ± 1.2 µM, respectively. The uptake of [3H]DNP-SG into
BBMVs was osmotically sensitive and stimulated to some extent by other
nucleotide triphosphates (GTP, CTP, and UTP) but not by ADP or AMP. An
ATPase inhibitor, vanadate, inhibited the ATP-dependent uptake of
[3H]DNP-SG to some extent. Reverse-transcriptase
polymerase chain reaction resulted in the amplification of MRP1, MRP3,
and MRP5. Northern blot analysis indicated extensive expression of
cMOAT/MRP2 and MRP3 and only minimal expression of MRP1 and MRP5.
Although cMOAT/MRP2 was continuously expressed throughout the culture
period, MRP3 was not expressed immediately after the confluent state
was reached. Collectively, the presence of ATP-dependent transport systems for DNP-SG and E217
G was demonstrated in Caco-2
cells. Because cMOAT/MRP2 and MRP3 may be expressed on brush-border and basolateral membranes in epithelial cells, respectively, the transport activity associated with BBMVs may result from the function of cMOAT/MRP2.
| |
Introduction |
|---|
|
|
|---|
The
intestinal mucosa is directly exposed to xenobiotics. To prevent the
invasion of xenobiotics, intestinal epithelial cells are equipped with
several enzymes such as cytochrome P-450 (Wacher et al., 1998
),
UDP-glucuronosyltransferase (Vargas and Franklin, 1997
), and
glutathione S-transferase (Gibbs et al., 1998
). In addition
to such metabolic enzymes, it has been established that P-glycoprotein
is located on the brush-border membrane of enterocytes to prevent the
entry of xenobiotics (Tsuji and Tamai, 1996
; Wacher et al., 1998
).
However, the excretion of xenobiotics from intestinal epithelial cells
cannot be completely accounted for by P-glycoprotein. It has been
established that, in the perfused rat small intestine, there is
intestinal excretion of the glucuronide conjugates of 1-naphthol (de
Vries et al., 1989
), 4-methylumbelliferone (4-MU) (Mulder et al.,
1984
), and ethinylestradiol (Schwenk et al., 1982
) formed in the
intestinal epithelium. In addition to these conjugated metabolites,
calcein is also excreted into the jejunum mucosa in a concentration-
and energy-dependent manner without any metabolic conversion (Fujita et
al., 1997
). Because P-glycoprotein primarily accepts amphipathic
cationic and neutral compounds as substrates (Kusuhara et al., 1998
),
the presence of transporters other than P-glycoprotein responsible for
the extrusion of anionic compounds has been postulated.
Concerning the cellular extrusion of organic anions, it has been shown
that the MRP family plays an important role (Deeley and Cole, 1997
;
Ishikawa et al., 1997
; Keppler and König, 1997
). In particular,
the role of cMOAT/MRP2 has been confirmed in the biliary excretion of
organic anions by comparing transport across the bile canalicular
membrane of normal rats and mutant rats whose cMOAT/MRP2 function is
hereditarily defective [e.g., transport-deficient (TR
) rats and Eisai hyperbilirubinemic rats
(EHBRs)] (Oude Elferink et al., 1995
; Kusuhara et al., 1998
; Suzuki
and Sugiyama, 1998
). Such comparison, along with the functional
analysis of cloned cMOAT/MRP2 product (Evers et al., 1998
; Ito et al.,
1998
; Kinoshita et al., 1998
; König et al., 1998
; van Aubel et
al., 1998
), has revealed that the substrates for cMOAT/MRP2 include
glutathione conjugates [e.g., leukotriene C4,
2,4-dinitrophenyl-S-glutathione (DNP-SG), and glutathione
disulfide], glucuronide conjugates [e.g., 17
-estradiol
17-(
-D-glucuronide)
(E217
G)], bilirubin glucuronides, and
glucuronide conjugates of xenobiotics [e.g.,
6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole (E3040) glucuronide and SN-38 glucuronide], and nonconjugated organic
anions (e.g., methotrexate, pravastatin, and carboxylate forms of
CPT-11 and its active metabolite) (Oude Elferink et al., 1995
; Keppler
and König, 1997
; Kusuhara et al., 1998
; Suzuki and Sugiyama,
1998
), and its substrates are similar to those of MRP1. Moreover,
Northern blot analysis has indicated the expression of cMOAT/MRP2 in
tissues from small intestine (Paulusma et al., 1996
; Ito et al., 1997
;
Kool et al., 1997
). In addition to cMOAT/MRP2, we recently found that
rat mrp3 can extrude organic anions (Hirohashi et al., 1999
). Although
mrp3 has been cloned as an inducible transporter in rat liver, it is
extensively expressed in the small intestine and colon of rat and human
(Kool et al., 1997
; Hirohashi et al., 1998
; Kiuchi et al., 1998
). It
has been shown that mrp3 accepts glucuronide conjugates (e.g.,
E217
G and E3040 glucuronide) and nonconjugated
organic anions (e.g., methotrexate) as suitable substrates. The
transport properties of mrp3, however, are different from those of MRP1
and cMOAT/MRP2 in that glutathione conjugates are poor substrates for
mrp3 (Hirohashi et al., 1999
).
In this study, we examined the possibility that the MRP family may be
responsible for the intestinal extrusion of organic anions. As an in
vitro model, we used Caco-2, a human colon adenocarcinoma cell line,
that retains many of the characteristics of normal enterocytes (Meunier
et al., 1995
). We examined the ATP-dependent transport of DNP-SG and
E217
G, typical substrates for the MRP family,
into the brush-border membrane vesicles (BBMVs) from Caco-2 cells. The
membrane vesicles from Caco-2 cells are particularly useful because 1)
it is impossible to obtain inside-out membrane vesicles from the small
intestine of experimental animals (Hsing et al., 1992
), and 2) Caco-2
cells retain the ability to excrete DNP-SG (Oude Elferink et al.,
1993
).
| |
Experimental Procedures |
|---|
|
|
|---|
Materials.
Unlabeled and [3H]DNP-SG
(50 µCi/nmol) were synthesized enzymatically with
[glycine-2-3H]glutathione (NEN Life Science
Products, Boston, MA), 1-chloro-2,4-dinitrobenzene, and glutathione
S-transferase (Sigma Chemical Co., St. Louis, MO) as
described previously (Kobayashi et al., 1990
). Unlabeled and
[3H]E217
G (51.0 µCi/nmol) were purchased from Sigma and NEN Life Science Products,
respectively. ATP, ADP, AMP, GTP, CTP, UTP, creatine phosphate,
creatine phosphokinase, sodium orthovanadate, and acivicin were
purchased from Sigma. All other chemicals used were commercially
available and of reagent grade.
Cell Culture.
Caco-2 cells (passage number 46-55) were
cultured in Dulbecco's modified Eagle's medium (25 mM glucose)
supplemented with 10% fetal calf serum, 0.1 mM nonessential amino
acids, 2 mM L-glutamine, penicillin (100 IU/ml),
streptomycin (100 µg/ml), and amphotericin B (250 ng/ml) in a
humidified incubator (5% CO2, 37°C). For
P-glycoprotein-mediated transport studies, Caco-2 cells with several
passage numbers have been used previously: 30 to 50 passages (Hosoya et
al., 1996
) and 85 to 105 passages (Hunter et al., 1993
). In each
passage, P-glycoprotein was functionally expressed.
Preparation of BBMVs.
For the preparation of BBMVs, Caco-2
cells were seeded in 20 incubation flasks (175 cm2) for 5 days after a confluent state was
reached. BBMVs were isolated by the CaCl2
precipitation method as described previously (Muranushi et al., 1994
)
and then frozen in liquid nitrogen and stored at
100°C until
required. Protein concentrations were determined by the Lowry method.
To determine the enrichment and orientation of BBMVs, the activity of
alkaline phosphatase, a marker enzyme for BBMVs, was measured in the
presence and absence of 0.1% Triton X-100 as described
previously (Niinuma et al., 1997
). Briefly, after the incubation of
BBMVs (1 µg protein) in the presence or absence of 0.1% Triton X-100
at room temperature for 30 min, BBMVs were incubated in 1 ml of the
mixture containing 5 mM p-nitrophenyl phosphate, 5 mM
MgCl2, 50 mM 2-amino-2-methylpropanol-HCl (pH 10.0) for 30 min. The reaction was terminated by the addition of 1 ml
10% trichloroacetic acid. The denatured protein was removed by
centrifugation, and the clear supernatant (1 ml) was neutralized by
addition of 2 ml of 1 N NaOH, and the amount of
p-nitrophenol released was determined colorimetrically
(A420).
Uptake of Ligands by BBMVs.
The transport study was
performed with the rapid-filtration technique (Ito et al., 1998
).
Transport medium (250 mM mannitol, 10 mM MgCl2,
and 10 mM Tris-HCl, pH 7.4) containing the radiolabeled ligands (15 µl), with or without unlabeled ligands, was preincubated at 37°C
for 3 min and then mixed with 5 µl membrane vesicle suspension (20 µg protein) with ATP (or AMP) and ATP-regenerating system (10 mM
creatine phosphate and 100 µg/ml creatine phosphokinase). To avoid
the degradation of DNP-SG by
-glutamyltranspeptidase (
-GTP),
BBMVs were incubated in 1 mM acivicin, an inhibitor of
-GTP, for 30 min at 25°C before starting the uptake of
[3H]DNP-SG. In some instances, ATP was replaced
by AMP, ADP, GTP, UTP, or CTP. The effect of vanadate (100 µM) on
ATP-dependent transport without ATP-regenerating system was also
examined. The transport reaction was stopped by the addition of 1 ml
ice-cold stop solution containing 250 mM mannitol, 0.1 M NaCl, and 10 mM Tris-HCl, pH 7.4. The stopped reaction mixture was filtered through a 0.45-µm mixed cellulose ester filter (Millipore Corp.,
Bedford, MA) and then washed twice with 5 ml of stop solution.
Radioactivity retained on the filter was determined with a liquid
scintillation counter (LSC-3500; Aloka Co., Tokyo, Japan). The
ATP-dependent uptake of ligands was calculated by subtracting the
ligand uptake in the absence of ATP from that in the presence of ATP.
Amplification of cDNA Fragments.
Total RNA was prepared by a
single-step guanidium thiocyanate procedure. Subsequently,
poly(A)+ RNA was purified with oligotex-dT30
(Takara Shuzo, Kyoto, Japan). The cDNA fragments encoding the
COOH-terminal ABC region of MRP1 (424 bp), MRP3 (422 bp), and MRP5 (423 bp) were amplified from Caco-2 cell polyA+ RNA by
reverse-transcriptase polymerase chain reaction (RT-PCR) with
degenerate PCR primers as described previously (Ito et al., 1997
). The
sequences of the forward and reverse primers were
5'-dGAGAAGGTCGGCAT-CGTGGG(AGTC)CG(AGTC)AC(AGTC)GG-3' and
5'-dGTCCACGGCTGC-(AGTC)GT(AGTC)GC(TC)TC(AG)TC-3', respectively. The
cDNA fragment encoding the COOH-terminal ABC region of cMOAT/MRP2 (603 bp) was amplified with a rigid primer for human cMOAT/MRP2 as a reverse
primer (5'-dAAAGGGTCCAGGGATTTGTAGCAGTTCTTC-3'). RT was performed with
random primer at 30°C for 10 min, 42°C for 30 min, 99°C for 5 min, and 5°C for 5 min. Then PCR was carried out at 94°C for
30 s, 37°C for 30 s and 72°C for 1 min for 40 cycles with
Taq polymerase. The amplified PCR products were subcloned into the EcoR V site of pBluescript II SK-(
) (Stratagene,
La Jolla, CA), and the sequence was determined. PCR products were excised from the vector by digestion with EcoRI and
HindIII and were used as probes to detect their expression.
Northern Blot Analysis. Poly(A)+ RNA was separated on 0.7% agarose gel containing 3.7% formaldehyde and transferred to a nylon membrane (Biodyne; Pall Co., Glen Cove, NY), before fixation by baking for 2 h at 80°C. The membranes were prehybridized in hybridization buffer containing 4 times standard saline citrate (SSC), five times Denhardt's solution, 0.2% SDS, 0.1 mg/ml of sonicated salmon sperm DNA, and 50% formamide for 2 h at 42°C and hybridized for 10 h at 42°C in the same buffer with a 32P-labeled cDNA probe that was prepared by a random primed labeling method (Rediprime, Amersham Pharmacia Biotech, Uppsala, Sweden). The hybridized membrane was washed in 2 times SSC and 0.1% SDS at room temperature for 20 min, followed by washing in 2 times SSC and 0.1% SDS at 55°C for 20 min and then in 0.1 times SSC and 0.1% SDS at 55°C for 20 min. The filters were exposed to an imaging plate, which was followed by analysis with a Fujix BAS 2000 image analyzer (Fuji Photo Film, Co., Ltd., Tokyo, Japan).
| |
Results |
|---|
|
|
|---|
Uptake of [3H]DNP-SG and
[3H]E217
G into BBMVs from Caco-2
Cells.
The enrichment of alkaline phosphatase in BBMVs from
5-day-old confluent Caco-2 cells was 8.94 ± 1.92-fold.
Determination of alkaline phosphatase in the presence and absence of
0.1% Triton X-100 revealed that 27.3 ± 3.6% of the membrane
vesicles were inside out.
G into BBMVs
in the presence or absence of ATP. ATP significantly stimulates the
uptake of both ligands (Fig. 1). In accordance with the reproducibility
in the enrichment of alkaline phosphatase and inside-out membrane
fractions, variation in the uptake of [3H]DNP-SG was minimal; uptake of
[3H]DNP-SG at 10 min was 4.46 ± 0.45 ml · min
1 · mg protein
1.
|
G was determined (Fig.
2). Nonlinear regression analysis showed
that the Km and
Vmax for the ATP-dependent uptake of
DNP-SG by BBMVs were 16.9 ± 7.2 µM and 5.0 ± 1.3 pmol · min
1 · mg
protein
1, respectively (Fig. 2A). The transport of
E217
G was also saturable and could be
described by a Km of 9.4 ± 1.1 µM and Vmax of 6.5 ± 0.6 pmol · min
1 · mg protein
1
(Fig. 2B).
|
Osmotic Sensitivity and Nucleotide Specificity of
[3H]DNP-SG Uptake into BBMVs from Caco-2 Cells.
To
confirm that the vesicle-associated uptake of
[3H]DNP-SG reflects transport into a vesicular
space rather than binding to the vesicle surface, the uptake of
[3H]DNP-SG was measured in the presence of
several concentrations of sucrose in the transport medium. The uptake
of [3H]DNP-SG into BBMVs was reduced by
increasing the sucrose concentration in the medium (Fig.
3). The y-intercept for the
relationship between the amount of DNP-SG associated with the vesicles
and the reciprocal of the sucrose concentration in the medium was 0.73 µl/mg of protein, indicating that the binding of DNP-SG to the
surface of vesicles was less than 15% when the transport experiment
was performed in isotonic medium (Fig. 3).
|
|
Northern Blot Analysis of the MRP Family in Caco-2 Cells. To identify the MRP family of molecules expressed in Caco-2 cells, RT-PCR was performed with the degenerated primers designed for the highly conserved COOH-terminal ABC region of human MRP1. Three MRP members (MRP1, 424 bp; MRP3, 422 bp; and MRP5, 423 bp) were amplified. cMOAT/MRP2 (603 bp) was amplified with a rigid primer for human cMOAT/MRP2 as a reverse primer. These results can be accounted for by considering that the degenerate primers used for this RT-PCR study were not suitable for the amplification of cMOAT/MRP2 because of a mismatch in the primer sequence.
The expression of MRP1, cMOAT/MRP2, MRP3, and MRP5 was examined with polyA+ RNA prepared from 0-, 5-, 7-, 10-, and 16-day-old confluent Caco-2 cells. cMOAT/MRP2 was highly expressed throughout the culture period, whereas the expression of MRP1 and MRP5 was minimal throughout this period (Fig. 4). The expression of MRP3 was markedly increased in 5-, 7-, 10-, and 16-day-old confluent cells compared with cells immediately after becoming confluent.
|
| |
Discussion |
|---|
|
|
|---|
It has been established that organic anions are excreted from
small intestinal epithelial cells via specific mechanisms (Schwenk et
al., 1982
; Mulder et al., 1984
; de Vries et al., 1989
; Fujita et al.,
1997
). However, little is known about the molecular mechanism by which
intestinal epithelial cells secrete these organic anions. Because MRP
family proteins, such as MRP1 and cMOAT/MRP2, are well known to accept
many organic anions including glutathione and glucuronide conjugates as
substrates (Oude Elferink et al., 1995
; Kusuhara et al., 1998
; Suzuki
and Sugiyama, 1998
), we hypothesized that the MRPs that are expressed
in the intestine are involved in the extrusion of these organic anions.
In this study, the transport of organic anions was examined in BBMVs
from Caco-2 cells, which are equipped with the characteristics of
normal enterocytes (Meunier et al., 1995
). In our preliminary experiments, we had difficulty in demonstrating the ATP-dependent uptake of [3H]DNP-SG or
[3H]E217
G into rat
intestinal BBMVs (T.H., H.S., and Y.S., unpublished observations) because these membrane vesicles are mostly
composed of right-side-out vesicles (Hsing et al., 1992
). Because 30%
of BBMVs from Caco-2 cells used in this study consisted of inside-out membrane vesicles (see Results), BBMVs from this cultured
cell line are useful for the study of active efflux transporters.
Although Oude Elferink et al. (1993)
found the energy-dependent efflux of DNP-SG across the apical and basal membrane of Caco-2 cells after
preloading its precursor (1-chloro-2,4-dinitrobenzene), little is known
about the molecular mechanism by which intestinal epithelial cells
secrete organic anions.
As shown in Fig. 1, [3H]DNP-SG and
[3H]E217
G were taken
up into BBMVs from Caco-2 cells in an ATP-dependent manner. No
overshoot, however, was observed for the uptake of these ligands up to
45 and 15 min, respectively (Fig. 1). The absence of overshoot for such
a relatively long incubation time has also been observed commonly in
membrane vesicles from several cultured cell lines (e.g.,
MRP1-overexpressing tumor cells or MRP1-transfected cells; Loe et al.,
1996
). These results are in contrast to the presence of marked
overshoot for the ATP-dependent uptake of
[3H]DNP-SG into isolated canalicular membrane
vesicles (CMVs) prepared from Sprague-Dawley rats (Niinuma et al.,
1997
). The difference may be because the ATP consumption is much less
in membrane vesicles from cultured cells than in CMVs. Indeed, in the
transport studies with CMVs, we have found rapid consumption of ATP in
the medium, resulting from the high ATPase activity associated with
these membrane vesicles (Watanabe et al., 1995
).
The ATP-dependent uptake of [3H]DNP-SG was
osmotically sensitive (Fig. 3), suggesting that the major part of the
uptake of [3H]DNP-SG is actually due to uptake
and not adsorption to the surface of BBMVs. As shown in Table 1, ADP
and AMP were unable to support [3H]DNP-SG
uptake. Of the four nucleotide triphosphates examined, ATP was the most
potent as far as the stimulation of [3H]DNP-SG
uptake was concerned. These observations, together with the fact that
the ATP-dependent uptake of [3H]DNP-SG was
inhibited by vanadate (an ATPase inhibitor), indicated that the
transport of [3H]DNP-SG by BBMVs requires ATP
hydrolysis. The presence of a stimulatory effect due to CTP, GTP, and
UTP on the uptake of [3H]DNP-SG (Table 1) is
consistent with the previous observations in rat CMVs (Kobayashi et
al., 1990
) and in membrane vesicles from human MRP1 or rat
cMOAT/MRP2-transfected cells (Loe et al., 1996
; Ito et al., 1998
),
suggesting that the MRP family is involved in the transport of this
glutathione conjugate.
Northern blot analysis with polyA+ RNA from
Caco-2 cells indicated that cMOAT/MRP2 and MRP3 are highly expressed,
whereas the expression of MRP1 and MRP5 is minimal (Fig. 4). This
result is consistent with the expression of these MRPs under
physiological conditions. Extensive expression of MRP3 in small
intestine and colon has been reported in rat and human (Kool et al.,
1997
; Hirohashi et al., 1998
; Kiuchi et al., 1998
; König et al.,
1999
). cMOAT/MRP2 is also expressed in the intestinal tissues of human,
rat, and rabbit (Ito et al., 1997
; Kool et al., 1997
). In contrast, the expression of MRP1 and MRP5 is minimal or undetectable in human intestinal tissues (Kruh et al., 1995
; Suzuki et al., 1997
). These results suggest that Caco-2 may reflect the in vivo situation of normal
enterocytes and is therefore useful as an in vitro model for the study
of the role of MRP family proteins in the small intestine.
The localization of cMOAT/MRP2 and MRP3 should be discussed in relation
to earlier findings. Previously, it was shown that cMOAT/MRP2 is
expressed on the bile canalicular (apical) membrane under physiological
conditions (Buchler et al., 1996
; Paulusma et al., 1996
; Keppler and
König, 1997
) and that this transporter is expressed on the
brush-border (apical) membrane of MDCK cells after cDNA transfection
(Evers et al., 1998
; Kinoshita et al., 1998
). In contrast, it was
recently shown that MRP3 is located on the basolateral membrane of
hepatocytes under physiological conditions (König et al., 1999
).
Collectively, it is plausible that cMOAT/MRP2 and MRP3 are expressed on
the brush-border and basolateral membranes of Caco-2 cells,
respectively. In addition, under physiological conditions, these
transporters may play a role in the efflux of their substrates from
intestinal epithelial cells into the luminal (exsorption) and
antiluminal (blood) sides (absorption) across the plasma membranes,
respectively. Indeed, the role of cMOAT/MRP2 in the small intestinal
excretion of DNP-SG has been demonstrated by comparing the behavior
between Sprague-Dawley rats and EHBRs in in vivo and in vitro
experiments (Ussing chamber and everted sacs studies; Goto et al., in press).
The direction of the efflux can be studied further in intact Caco-2 monolayers. Our preliminary experiments indicated that glutathione-bimane, a substrate for cMOAT/MRP2 but not for MRP3, is excreted predominantly in the apical direction after preloading Caco-2 cells with its precursor (monochlorobimane). In contrast, 4-MU glucuronide was excreted almost equally to the apical and basal sides after preloading Caco-2 monolayers with its precursor (4-MU) (A. Seta, H.S., and S.Y., unpublished observations). Because 4-MU glucuronide may be recognized by both cMOAT/MRP2 and MRP3, these data can be accounted for by assuming that both the apical and basal efflux of 4-MU glucuronide is mediated by cMOAT/MRP2 and MRP3, respectively.
The results of the kinetic analysis of the transport studies also
suggest the expression of cMOAT/MRP2 in BBMVs. The
Km value for DNP-SG and
E217
G were determined to be 16.9 ± 7.2 and 9.4 ± 1.1 µM, respectively (Fig. 2). These values are in
good agreement with the previously determined
Km values; with membrane vesicles isolated from HEK 293 cells transfected with human cMOAT cDNA, the
Km value for
E217
G was determined to be 7.2 ± 0.7 µM (König et al., 1998
). In the same manner, the
Km for DNP-SG was determined to be 5.6 µM in membrane vesicles from MDCK cells transfected with the same
cDNA (Evers et al., 1998
). In contrast, the transport characteristics
of rat mrp3 are different from those of MRP1 and cMOAT/MRP2 in that the
glucuronide conjugates, but not glutathione conjugates, are good
substrates for MRP3 (Hirohashi et al., 1999
). Moreover, the
Km value for
E217
G by mrp3 was 110 and 67 µM in mrp3-transfected LLC-PK1 and HeLa cells, respectively (Hirohashi et
al., 1999
), which is much higher than that reported for cMOAT/MRP2 (König et al., 1998
). Considering these results, it is possible that the ATP-dependent uptake observed in BBMVs from Caco-2 cells is
mainly mediated by cMOAT/MRP2 rather than MRP3.
In culture, Caco-2 differentiated into polarized cell monolayers with
the characteristics of intestinal epithelial cells. Because some
reports have been published showing that the function and expression of
P-glycoprotein is increased to some extent during culture (Hosoya et
al., 1996
), the expression of MRPs was determined as a function of the
culture period in this study (Fig. 4). Moreover, we normalized the
expression levels of cMOAT/MRP2 and MRP3 by GAPDH with a densitometer.
The relative expression level of these transporters, obtained by
dividing by that of GAPDH, is summarized in Table
2. Although the relative expression of
cMOAT/MRP2 increased in 5-day-confluent Caco-2 cells (2-fold) compared
with that in 0-day-confluent cells, it was not significantly different
from the cells at 7 (1.9-fold) and 10 (1.8-fold) days after becoming confluent (Table 2). However, a reduction in the relative expression level of cMOAT/MRP2 was observed in 16-day-confluent cells (only 1.2-fold higher than that of 0-day-confluent cells) (Table 2). The
relative expression level of MRP3 markedly increased during the first 5 days after becoming confluent (5.8-fold) and exhibited small changes in
7- (6.2-fold), 10- (10-fold), and 16-day (4.8-fold) cultures. Because
the purpose of this study was to demonstrate the presence of primary
active transporter(s) for organic anions in Caco-2 cells, we have
isolated BBMVs from Caco-2 cells at 5 days confluent, when the
expression level of the MRP family is greatest. Currently, we cannot
exclude the possibility that the transport properties of the MRP family
are different depending on the culture days.
|
In conclusion, we have demonstrated the presence of ATP-dependent transporters in Caco-2 cells by use of BBMVs. Because both MRP2 and MRP3 are also expressed in Caco-2 and in human intestinal tissues, membrane vesicles from Caco-2 cells represent a good tool for investigating the functions of MRPs as in vitro models of the human intestine.
| |
Footnotes |
|---|
Accepted for publication September 15, 1999.
Received for publication June 1, 1999.
1 This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas "ABC proteins" (10044243) from the Ministry of Education, Science, and Culture of Japan.
Send reprint requests to: Hiroshi Suzuki, Ph.D., Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku. E-mail: suzuki{at}seizai.f.u-tokyo.ac.jp
| |
Abbreviations |
|---|
BBMVs, brush-border membrane vesicles;
ABC, ATP-binding cassette;
MRP, multidrug resistance-associated protein;
cMOAT, canalicular multispecific organic anion transporter;
EHBR, Eisai
hyperbilirubinemic rat;
DNP-SG, 2,4-dinitrophenyl-S-glutathione;
E217
G, 17
-estradiol 17-
-D-glucuronide;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
4-MU, 4-methylumbelliferone.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
W. Brand, P. A. I. van der Wel, M. J. Rein, D. Barron, G. Williamson, P. J. van Bladeren, and I. M. C. M. Rietjens Metabolism and Transport of the Citrus Flavonoid Hesperetin in Caco-2 Cell Monolayers Drug Metab. Dispos., September 1, 2008; 36(9): 1794 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Callaghan, E. Crowley, S. Potter, and I. D. Kerr P-glycoprotein: So Many Ways to Turn It On J. Clin. Pharmacol., March 1, 2008; 48(3): 365 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Meinl, B. Ebert, H. Glatt, and A. Lampen Sulfotransferase Forms Expressed in Human Intestinal Caco-2 and TC7 Cells at Varying Stages of Differentiation and Role in Benzo[a]pyrene Metabolism Drug Metab. Dispos., February 1, 2008; 36(2): 276 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sun and K. S. Pang Permeability, Transport, and Metabolism of Solutes in Caco-2 Cell Monolayers: A Theoretical Study Drug Metab. Dispos., January 1, 2008; 36(1): 102 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Glavinas, E. Kis, A. Pal, R. Kovacs, M. Jani, E. Vagi, E. Molnar, S. Bansaghi, Z. Kele, T. Janaky, et al. ABCG2 (Breast Cancer Resistance Protein/Mitoxantrone Resistance-Associated Protein) ATPase Assay: A Useful Tool to Detect Drug-Transporter Interactions Drug Metab. Dispos., September 1, 2007; 35(9): 1533 - 1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Lai, L. Xing, G. I. Poda, and Y. Hu Structure-Activity Relationships for Interaction with Multidrug Resistance Protein 2 (ABCC2/MRP2): The Role of Torsion Angle for a Series of Biphenyl-Substituted Heterocycles Drug Metab. Dispos., June 1, 2007; 35(6): 937 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Deeley, C. Westlake, and S. P. C. Cole Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins. Physiol Rev, July 1, 2006; 86(3): 849 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hirano, K. Maeda, H. Hayashi, H. Kusuhara, and Y. Sugiyama Bile Salt Export Pump (BSEP/ABCB11) Can Transport a Nonbile Acid Substrate, Pravastatin J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 876 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Xiao, A. B. Foraker, P. W. Swaan, S. Liu, Y. Huang, Z. Dai, J. Chen, W. Sadee, J. Byrd, G. Marcucci, et al. Efflux of Depsipeptide FK228 (FR901228, NSC-630176) Is Mediated by P-Glycoprotein and Multidrug Resistance-Associated Protein 1 J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 268 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Prime-Chapman, R. A. Fearn, A. E. Cooper, V. Moore, and B. H. Hirst Differential Multidrug Resistance-Associated Protein 1 through 6 Isoform Expression and Function in Human Intestinal Epithelial Caco-2 Cells J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 476 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shoji, H. Suzuki, H. Kusuhara, Y. Watanabe, S. Sakamoto, and Y. Sugiyama ATP-dependent transport of organic anions into isolated basolateral membrane vesicles from rat intestine Am J Physiol Gastrointest Liver Physiol, October 1, 2004; 287(4): G749 - G756. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mizuno, T. Niwa, Y. Yotsumoto, and Y. Sugiyama Impact of Drug Transporter Studies on Drug Discovery and Development Pharmacol. Rev., September 1, 2003; 55(3): 425 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suzuki, H. Suzuki, Y. Sugimoto, and Y. Sugiyama ABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics J. Biol. Chem., June 13, 2003; 278(25): 22644 - 22649. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Elimrani, K. Lahjouji, E. Seidman, M.-J. Roy, G. A. Mitchell, and I. Qureshi Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells Am J Physiol Gastrointest Liver Physiol, May 1, 2003; 284(5): G863 - G871. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Trauner and J. L. Boyer Bile Salt Transporters: Molecular Characterization, Function, and Regulation Physiol Rev, April 1, 2003; 83(2): 633 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. J. Wacher, J. A. Silverman, S. Wong, P. Tran-Tau, A. O. Chan, A. Chai, X.-Q. Yu, D. O'Mahony, and Z. Ramtoola Sirolimus Oral Absorption in Rats Is Increased by Ketoconazole but Is Not Affected by D-alpha -Tocopheryl Poly(Ethylene Glycol 1000) Succinate J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 308 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Merino, A. I. Alvarez, J. G. Prieto, and R. B. Kim The Anthelminthic Agent Albendazole Does Not Interact with P-Glycoprotein Drug Metab. Dispos., April 1, 2002; 30(4): 365 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rost, S. Mahner, Y. Sugiyama, and W. Stremmel Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine Am J Physiol Gastrointest Liver Physiol, April 1, 2002; 282(4): G720 - G726. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Naruhashi, I. Tamai, N. Inoue, H. Muraoka, Y. Sai, N. Suzuki, and A. Tsuji Involvement of Multidrug Resistance-Associated Protein 2 in Intestinal Secretion of Grepafloxacin in Rats Antimicrob. Agents Chemother., February 1, 2002; 46(2): 344 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakamura, T. Sakaeda, N. Ohmoto, T. Tamura, N. Aoyama, T. Shirakawa, T. Kamigaki, T. Nakamura, K. I. Kim, S. R. Kim, et al. Real-Time Quantitative Polymerase Chain Reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA Levels in Caco-2 Cell Lines, Human Duodenal Enterocytes, Normal Colorectal Tissues, and Colorectal Adenocarcinomas Drug Metab. Dispos., January 1, 2002; 30(1): 4 - 6. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Inokuchi, E. Hinoshita, Y. Iwamoto, K. Kohno, M. Kuwano, and T. Uchiumi Enhanced Expression of the Human Multidrug Resistance Protein 3 by Bile Salt in Human Enterocytes. A TRANSCRIPTIONAL CONTROL OF A PLAUSIBLE BILE ACID TRANSPORTER J. Biol. Chem., December 7, 2001; 276(50): 46822 - 46829. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Taipalensuu, H. Tornblom, G. Lindberg, C. Einarsson, F. Sjoqvist, H. Melhus, P. Garberg, B. Sjostrom, B. Lundgren, and P. Artursson Correlation of Gene Expression of Ten Drug Efflux Proteins of the ATP-Binding Cassette Transporter Family in Normal Human Jejunum and in Human Intestinal Epithelial Caco-2 Cell Monolayers J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 164 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Hochman, M. Chiba, M. Yamazaki, C. Tang, and J. H. Lin P-glycoprotein-Mediated Efflux of Indinavir Metabolites in Caco-2 Cells Expressing Cytochrome P450 3A4 J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 323 - 330. [Abstract] [Full Text] |
||||
![]() |
L. C. Young, B. G. Campling, S. P. C. Cole, R. G. Deeley, and J. H. Gerlach Multidrug Resistance Proteins MRP3, MRP1, and MRP2 in Lung Cancer: Correlation of Protein Levels with Drug Response and Messenger RNA Levels Clin. Cancer Res., June 1, 2001; 7(6): 1798 - 1804. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Stephens, C. A. O'Neill, A. Warhurst, G. L. Carlson, M. Rowland, and G. Warhurst Kinetic Profiling of P-glycoprotein-Mediated Drug Efflux in Rat and Human Intestinal Epithelia J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 584 - 591. [Abstract] [Full Text] |
||||
![]() |
H. Li, S.-J. Chung, D.-C. Kim, H.-S. Kim, J.-W. Lee, and C.-K. Shim The Transport of a Reversible Proton Pump Antagonist, 5,6-Dimethyl-2-(4-Fluorophenylamino)-4-(1-Methyl-1,2,3,4- Tetrahydroisoquinoline-2-yl) Pyrimidine Hydrochloride (YH1885), across Caco-2 Cell Monolayers Drug Metab. Dispos., January 1, 2001; 29(1): 54 - 59. [Abstract] [Full Text] |
||||
![]() |
N. Okudaira, I. Komiya, and Y. Sugiyama Polarized Efflux of Mono- and Diacid Metabolites of ME3229, an Ester-Type Prodrug of a Glycoprotein IIb/IIIa Receptor Antagonist, in Rat Small Intestine J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 717 - 723. [Abstract] [Full Text] |
||||
![]() |
M. F. Fromm, H.-M. Kauffmann, P. Fritz, O. Burk, H. K. Kroemer, R. W. Warzok, M. Eichelbaum, W. Siegmund, and D. Schrenk The Effect of Rifampin Treatment on Intestinal Expression of Human MRP Transporters Am. J. Pathol., November 1, 2000; 157(5): 1575 - 1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamaguchi, I. Yano, Y. Hashimoto, and K.-I. Inui Secretory Mechanisms of Grepafloxacin and Levofloxacin in the Human Intestinal Cell Line Caco-2 J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 360 - 366. [Abstract] [Full Text] |
||||
![]() |
N. Okudaira, T. Tatebayashi, G. C. Speirs, I. Komiya, and Y. Sugiyama A Study of the Intestinal Absorption of an Ester-Type Prodrug, ME3229, in Rats: Active Efflux Transport as a Cause of Poor Bioavailability of the Active Drug J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 580 - 587. [Abstract] [Full Text] |
||||
![]() |
A. D. Mottino, T. Hoffman, L. Jennes, and M. Vore Expression and Localization of Multidrug Resistant Protein mrp2 in Rat Small Intestine J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 717 - 723. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||